Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CB | P42338 | 19/20 | 0.71 |
| ▸ | PIK3CA | P42336 | 15/20 | 0.65 |
| ▸ | PIK3CD | O00329 | 14/20 | 0.62 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.62 |
| ▸ | PIK3R1 | P27986 | 13/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL909603 | 0.86 | PIK3CB (0.90) | PIK3CBPIK3CAPIK3CDPIK3CGPIK3R1 | |
| SCHEMBL31157034 | 0.84 | PIK3CB (0.90) | PIK3CBPIK3CAPIK3CDPIK3CGPIK3R1 | |
| SCHEMBL477354 | 0.84 | PIK3CB (0.90) | PIK3CBPIK3CAPIK3CDPIK3CGPIK3R1 | |
| SCHEMBL477384 | 0.84 | PIK3CB (0.69) | PIK3CBPIK3CAPIK3CDPIK3CGPIK3R1 | |
| SCHEMBL3566232 | 0.80 | PIK3CB (1.00) | PIK3CBPIK3CAPIK3CDPIK3CGPIK3R1 | |
| SCHEMBL12789644 | 0.79 | PIK3CB (0.67) | PIK3CBPIK3CAPIK3CDPIK3CGPIK3R1 | |
| SCHEMBL3563102 | 0.79 | PIK3CB (1.00) | PIK3CBPIK3CAPIK3CDPIK3CGPIK3R1 | |
| SCHEMBL17004656 | 0.77 | PIK3CB (0.94) | PIK3CBPIK3CAPIK3CDPIK3CGPIK3R1 | |
| SCHEMBL2818070 | 0.76 | PIK3CB (1.00) | PIK3CBPIK3CAPIK3CDPIK3CGPIK3R1 | |
| SCHEMBL2812275 | 0.76 | PIK3CB (1.00) | PIK3CBPIK3CAPIK3CDPIK3CGPIK3R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2276750-A2 | SUBSTITUTED PYRIMIDINES AND TRIAZINES AND THEIR USE IN CANCER THERAPY | Auckland Uniservices Limited (NZ) | 2011-01-26 | — | — | EP | disclosed |